
- Applied Clinical Trials-09-01-2020
- Volume 29
- Issue 9
Trial Innovation Beyond the COVID-19 Pandemic
A look into the future based off what we've learned about trials during the pandemic.
As of Sept. 1, 2020, ClinicalTrials.gov lists 284 clinical trials as suspended. Not all of those trials are suspended for COVID-19, some are holdovers on financial issues, R&D problems, etc. And while upwards of 1,200 trials were suspended at the peak,
Solutions to enhance patient participation
According to press releases and reports of the time, solutions to ensure that participants could continue to stay in clinical trials safely were on the rise. In
During the pandemic, service providers offering safe patient access and decentralized model enablement, found increased interest in their business. Darcy Forman, vice president of clinical operations for Science 37, a provider of virtual clinical trials, commented at the time, “We have been unbelievably busy with this pandemic as sponsors are wanting to transition to a virtual model. It’s really accelerating, and they are finally pushing through their hesitancy.”
In
That sense of urgency and can-do attitude is what our event will highlight. We are currently recruiting speakers to share their experiences in the following topic areas: the patient participation piece; the New Clinical Trial and how sites and sponsors transitioned to address the barriers of COVID; and Ensuring Data Quality and eSource Implementation—again another “old is new again” strategy to gain forward momentum in the clinical trial discourse. We look forward to sharing your ideas during this forum.
Lisa Henderson is Editor-in-Chief of Applied Clinical Trials. She can be reached at
Articles in this issue
about 5 years ago
News Notesabout 5 years ago
Innovative Clinical Trial Designs Emerge from Pandemicabout 5 years ago
Applying Pre-Pandemic Benchmarks to Assess Future Speed Strategiesabout 5 years ago
Silver Linings of Post-Pandemic Trial Disruptionabout 5 years ago
Debate Accelerates Over Who Gets COVID Vaccine Firstabout 5 years ago
FDA’s ‘Gold Standard’ Critical for Biopharma R&Dabout 5 years ago
Decentralized Trials: Opening New Opportunities in Clinical Researchabout 5 years ago
The Rise of FSP Outsourcing in Drug Developmentabout 5 years ago
Small Biopharma and CROs: Seeking Stronger SynergiesNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.